Experts Matter. Find Yours.

Connect for media, speaking, professional opportunities & more.

Filters

Locke Bryan, PhD profile photo

Locke Bryan, PhD

Medical Hematologist-OncologistGeorgia Cancer Center at Augusta University

A leading medical hematologist-oncologist who also specializes in Lymphomas Immunotherapy Novel Therapeutics.

Lymphomas Immunotherapy Novel TherapeuticsCancer
Michael H. Peters, Ph.D. profile photo

Michael H. Peters, Ph.D.

Professor, Department of Chemical and Life Science EngineeringVCU College of Engineering

Professor Peters conducts experimental and theoretical research in the field of protein engineering.

Peptidyl-Biomimetics Inhibitors for Breast Cancer TargetsOpenContact: A Simple Static Protein-Protein Mapping AlgorithmExtended Liouville Equation for Open SystemsNeuronal Stem Cell Delivery SystemsProtein Engineering
Elisabeth Barton profile photo

Elisabeth Barton

Professor | Associate DeanUniversity of Florida

Elisabeth Barton is a molecular physiologist with a primary interest in skeletal muscle repair.

SpaceViral Gene TherapyOptimization of IGF-I for Muscle TherapeuticsMechanical Signal TransductionSkeletal Muscle Repair
Gerry Brunk profile photo

Gerry Brunk

Managing DirectorLumira Ventures

Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.

Business StrategyMedical DevicesPharmaceutical IndustryDrug DevelopmentCommercialization
Bruce Armitage profile photo

Bruce Armitage

Professor and Co-DirectorCarnegie Mellon University

Bruce Armitage’s current research interests include the use of PNA for sequence-specific recognition of DNA and RNA.

Peptide Nucleic AcidsDNA NanotechnologyBioorganic ChemistryFluorescent DyesMolecular Evolution
John McCulloch profile photo

John McCulloch

Founder & Managing DirectorBurloch Group Inc.

Engaging and knowledgeable speaker with deep expertise in biotechnology investment.

BiotechnologyPharmaceuticalsInnovationInvestment
Robert Lanza profile photo

Robert Lanza

ScientistOcata Therapeutics

Robert Lanza is currently Chief Scientific Officer at Ocata Therapeutics and Adjunct Professor at Wake Forest University School of Medicine.

biocentrismScienceResearchRegenerative Medicine
Riccardo Panicucci profile photo

Riccardo Panicucci

Senior VP CMCQED Therapeutics and Origin Biosciences

Riccardo Panicucci is an expert in the pharmaceutical industry, biotechnology, clinical development, and biopharmaceuticals.

Technology TransferBiotechnologyClinical DevelopmentDrug DiscoveryDrug Development
Dr. Mark Ware profile photo

Dr. Mark Ware

Chief Medical OfficerCanopy Growth

Dr. Ware leads Canopy Growth’s medical division, Spectrum Therapeutics including research towards the development of cannabinoid medicines.

Endocannabinoid SystemCannabis ResearchCannabinoidsMedical CannabisClinical Research
Emily Walsh profile photo

Emily Walsh

Principal ConsultantHalloran Consulting Group, Inc.

Recovering Scientist

Personalized Medicine and GeneticsTranslational MedicineTransitioning From the BenchProject Management 101Program Management 101